Adynxx

$2.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.21 (-33.52%) Today
$0.00 (0.00%) As of 4:46 PM EDT after-hours

Why Robinhood?

You can watch Adynxx and buy or sell other stocks, options, ETFs, and crypto commission-free!

About ADYX

Adynxx, Inc. Common Stock, also called Adynxx, is a clinical stage biopharmaceutical company. Read More The Company is focused on development of non-opioid therapeutics for the treatment of pain and inflammatory diseases. Its AYX platform utilizes a proprietary technology of non-opioid, disease-modifying transcription factor decoys. Its pipeline includes brivoligide and AYX2. Brivoligide product candidate is a potent and selective inhibitor of the transcription factor EGR1. Brivoligide is being developed for the prevention of post-surgical pain. AYX2 is a potent inhibitor of Kruppel-like Factors (KLF) six, nine and 15, transcription factors that maintain neuronal and glial activities involved in pain. AYX2 is being developed for the long-term suppression of chronic pain.

Employees
6
Headquarters
San Francisco, CA
Founded
2007
Market Cap
55.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.90K
High Today
$2.60
Low Today
$2.40
Open Price
$2.55
Volume
3.27K
52 Week High
$19.15
52 Week Low
$1.92
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.